Rotorua Daily Post
  • Rotorua Daily Post home
  • Latest news
  • Business
  • Opinion
  • Lifestyle
  • Property
  • Sport
  • Video
  • Death notices
  • Classifieds

Subscriptions

  • Herald Premium
  • Viva Premium
  • The Listener
  • BusinessDesk

Sections

  • Latest news
  • On The Up
  • Business
  • Opinion
  • Lifestyle
    • All Lifestyle
    • Residential property listings
  • Property
    • All Property
    • Dairy farming
    • Sheep & beef farming
    • Horticulture
    • Animal health
    • Rural business
    • Rural life
    • Rural technology
  • Rural
  • Sport

Locations

  • Tauranga
  • Te Puke
  • Whakatāne
  • Rotorua
  • Tokoroa
  • Taupō & Tūrangi

Media

  • Video
  • Photo galleries
  • Today's Paper - E-Editions
  • Photo sales

Weather

  • Rotorua
  • Tauranga
  • Whakatāne
  • Tokoroa
  • Taupō

NZME Network

  • Advertise with NZME
  • OneRoof
  • Driven Car Guide
  • BusinessDesk
  • Newstalk ZB
  • Sunlive
  • ZM
  • The Hits
  • Coast
  • Radio Hauraki
  • The Alternative Commentary Collective
  • Gold
  • Flava
  • iHeart Radio
  • Hokonui
  • Radio Wanaka
  • iHeartCountry New Zealand
  • Restaurant Hub
  • NZME Events

SubscribeSign In
Advertisement
Advertise with NZME.
Home / Rotorua Daily Post

Breast cancer chemo drug trial recruiting in Rotorua

Rotorua Daily Post
27 Jun, 2019 04:06 AM2 mins to read

Subscribe to listen

Access to Herald Premium articles require a Premium subscription. Subscribe now to listen.
Already a subscriber?  Sign in here

Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech.
‌
Save

    Share this article

Dr Richard Isaacs. Photo / Breast Cancer Trials

Dr Richard Isaacs. Photo / Breast Cancer Trials

A clinical trial that's now recruiting patients in Rotorua will test the ability of a cheap, widely available drug to prevent two of chemotherapy's most unpleasant side-effects.

Breast Cancer Foundation NZ committed $250,000 last year to the PantoCIN trial.

More than 160 breast cancer patients will be recruited at up to 10 hospitals around New Zealand, and Rotorua is one of the first to open the trial.

Between half and 80 per cent of patients suffer delayed nausea and vomiting from two to five days after chemo, which can have a severe impact on their quality of life.

The PantoCIN trial is being led by medical oncologists Richard Isaacs and Navin Wewala from Palmerston North Hospital.

Advertisement
Advertise with NZME.
Advertisement
Advertise with NZME.

Happy New Year, we hope 2019 is a good year for you all. CTNZ has an exciting time coming up with the opening of our new breast cancer trial, PantoCIN #PantoCIN in March/April and continued recruitment to THYmine 2, KISS and PROSPER #clinicaltrials #CancerResearch #breastcancer

— Cancer Trials New Zealand (@CancerTrialsNZ) January 2, 2019

It is co-funded by Breast Cancer Trials Australia NZ, an international trials group that has led many of the region's largest clinical trials.

"We're hoping this trial will provide an affordable, effective means of reducing these side effects," Isaacs said.

The trial's primary target is a complete absence of delayed nausea and vomiting for many patients.

Advertisement
Advertise with NZME.

Evangelia Henderson, chief executive at Breast Cancer Foundation NZ, said she was delighted the trial was now recruiting.

"We don't have a lot of multi-centre breast cancer clinical trials in New Zealand, so we see this as a great chance for our hospitals to build their experience in collaborating in this kind of venture."

Patients enrolling in the trial will take either the trial drug, pantoprazole, or a placebo for their first chemo cycle, then will swap around for the second cycle.

Pantoprazole is a type of medicine called a proton-pump inhibitor (PPI), designed to reduce gastric acid.

Discover more

New Zealand

'It was horrific': Beagle mauled, daughter bitten in vicious dog attack

22 Jun 07:26 AM

Our People: Dissecting Mike Creswell's medical career

22 Jun 12:15 AM

Police appeal for information after pedestrian struck in Taupō

22 Jun 06:00 AM
New Zealand

Former teacher fighting cancer dies

25 Jun 11:30 PM

It was chosen because of its mild side-effects and low likelihood of interaction with other medications, and its high bioavailability (the proportion of the drug that enters the bloodstream to have an active effect).

Find out about eligibility criteria at www.breastcancerfoundation.org.nz/clinical-trials

If you'd like to take part in the trial, talk to your oncologist.

Save

    Share this article

Latest from Rotorua Daily Post

Rotorua Daily Post

New Rotorua police beat team to tackle 'big' retail crime issues

03 Jul 07:03 AM
Rotorua Daily Post

Heavy rain warnings: BoP acts like 'scoop' for wild weather

02 Jul 09:19 PM
Rotorua Daily Post

Heating or eating a tough call for some after rates rise, says councillor

02 Jul 09:13 PM

There’s more to Hawai‘i than beaches and buffets – here’s how to see it differently

sponsored
Advertisement
Advertise with NZME.

Latest from Rotorua Daily Post

New Rotorua police beat team to tackle 'big' retail crime issues

New Rotorua police beat team to tackle 'big' retail crime issues

03 Jul 07:03 AM

The team comprises five constables and one sergeant, patrolling on foot.

Heavy rain warnings: BoP acts like 'scoop' for wild weather

Heavy rain warnings: BoP acts like 'scoop' for wild weather

02 Jul 09:19 PM
Heating or eating a tough call for some after rates rise, says councillor

Heating or eating a tough call for some after rates rise, says councillor

02 Jul 09:13 PM
Armed police block Rotorua street

Armed police block Rotorua street

02 Jul 09:10 PM
From early mornings to easy living
sponsored

From early mornings to easy living

NZ Herald
  • About NZ Herald
  • Meet the journalists
  • Newsletters
  • Classifieds
  • Help & support
  • Contact us
  • House rules
  • Privacy Policy
  • Terms of use
  • Competition terms & conditions
  • Our use of AI
Subscriber Services
  • Rotorua Daily Post e-edition
  • Manage your print subscription
  • Manage your digital subscription
  • Subscribe to Herald Premium
  • Subscribe to the Rotorua Daily Post
  • Gift a subscription
  • Subscriber FAQs
  • Subscription terms & conditions
  • Promotions and subscriber benefits
NZME Network
  • Rotorua Daily Post
  • The New Zealand Herald
  • The Northland Age
  • The Northern Advocate
  • Waikato Herald
  • Bay of Plenty Times
  • Hawke's Bay Today
  • Whanganui Chronicle
  • Viva
  • NZ Listener
  • Newstalk ZB
  • BusinessDesk
  • OneRoof
  • Driven Car Guide
  • iHeart Radio
  • Restaurant Hub
NZME
  • About NZME
  • NZME careers
  • Advertise with NZME
  • Digital self-service advertising
  • Book your classified ad
  • Photo sales
  • NZME Events
  • © Copyright 2025 NZME Publishing Limited
TOP